Chimeric oligomeric compounds and their use in gene modulation

Details for Australian Patent Application No. 2011203091 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Crooke, Stanley T.; Baker, Brenda F.; Eldrup, Anne B.; Manoharan, Muthiah; Bhat, Balkrishen; Griffey, Richard; Swayze, Eric E.

Agent Pizzeys

Pub. Number AU-A-2011203091

Parent 2003287505

Filing date 24 June 2011

Wipo publication date 14 July 2011

International Classifications

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

14 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203091

14 July 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203092-Measuring device for measuring consistency of cement slurry for a consistometer

2011203090-Biofuel Production